Who
Dana Yaacov-Garbeli
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Entera Bio.
In numbers
- Trades disclosed
- 14
- Buys
- 2
- Sells
- 0
- Bought
- $30K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Sep 2022
- Last trade
- 7 Aug 2026
- Last filed
- 7 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 7 Aug 2026filed 7 Aug 2026 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —58,394 at $0.00 | filing |
| 7 May 2026filed 8 May 2026 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —58,394 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —26,316 at $0.00 | filing |
| 19 Apr 2024filed 2 Aug 2024 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 19 Apr 2024filed 2 Aug 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —30,151 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —130,000 at $0.00 | filing |
| 19 Apr 2024filed 23 Apr 2024 | ENTX Entera BioBiotechnology | SEC FORM 4 Code A | —30,151 at $0.00 | filing |
| 24 Apr 2023filed 25 Apr 2023 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —190,000 at $0.00 | filing |
| 14 Nov 2022filed 15 Nov 2022 | ENTX Entera BioBiotechnology | SEC FORM 4 Bought | $14K26,580 at $0.54 | filing |
| 11 Nov 2022filed 15 Nov 2022 | ENTX Entera BioBiotechnology | SEC FORM 4 Bought | $16K30,000 at $0.52 | filing |
| 7 Sep 2022filed 9 Sep 2022 | ENTX Entera Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.